Publication | Closed Access

BTLA marks a less cytotoxic T-cell subset in diffuse large B-cell lymphoma with high expression of checkpoints

Hematological MalignancyLymphoid NeoplasiaCancer ImmunosurveillanceMedicineImmunologyHigh ExpressionPathologyCytotoxic T-cell SubsetAutoimmunityAdult T-cell Leukemia-lymphomaImmunotherapyOncology